What does Isentress (raltegravir) do for HIV?
Isentress is an antiretroviral medicine (raltegravir) used in combination therapy to treat HIV-1 infection [1]. Its main benefit is lowering the amount of HIV in the body (viral load), which helps preserve immune function and reduce the risk of HIV progression [1].
How does viral control translate into clinical outcomes?
By suppressing HIV replication, effective treatment with regimens that include Isentress can:
- Reduce viral load to undetectable levels for many people on therapy [1]
- Help keep CD4 cell counts from falling, supporting immune recovery over time [1]
- Reduce the likelihood of HIV-related complications associated with uncontrolled infection [1]
Who is Isentress for?
Isentress is used as part of combination antiretroviral therapy, including in certain adult and pediatric patients depending on the prescribing guidance and available formulations [1].
What benefits might people notice compared with older regimens?
The benefit people are looking for with Isentress is that it can be used to achieve strong HIV viral suppression as part of an appropriately constructed regimen [1]. The practical “advantage” in day-to-day use depends on what other medicines are combined with and how well the overall regimen matches the patient’s situation (other drugs, comorbidities, prior treatment history).
What to know about tolerability and safety when weighing benefits?
Any benefit from Isentress has to be balanced against potential side effects and drug interactions, since it is used with other antiretrovirals [1]. If you’re deciding whether it fits a regimen, the prescriber will consider the full combination, not Isentress alone [1].
Source
[1] https://www.drugpatentwatch.com/patent/isentress-raltegravir/